Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 67
1985 76
1986 63
1987 104
1988 160
1989 185
1990 235
1991 280
1992 290
1993 298
1994 314
1995 341
1996 314
1997 297
1998 303
1999 294
2000 232
2001 264
2002 262
2003 275
2004 295
2005 239
2006 319
2007 356
2008 402
2009 298
2010 350
2011 385
2012 382
2013 371
2014 444
2015 399
2016 315
2017 251
2018 273
2019 172
2020 238
2021 173
2022 309
2023 249
2024 179
2025 191
2026 127

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,257 results

Results by year

Filters applied: . Clear all
Page 1
Stability of Protein Pharmaceuticals: Recent Advances.
Manning MC, Holcomb RE, Payne RW, Stillahn JM, Connolly BD, Katayama DS, Liu H, Matsuura JE, Murphy BM, Henry CS, Crommelin DJA. Manning MC, et al. Pharm Res. 2024 Jul;41(7):1301-1367. doi: 10.1007/s11095-024-03726-x. Epub 2024 Jun 27. Pharm Res. 2024. PMID: 38937372 Review.
IVIVC Revised.
Alimpertis N, Simitopoulos A, Tsekouras AA, Macheras P. Alimpertis N, et al. Pharm Res. 2024 Feb;41(2):235-246. doi: 10.1007/s11095-024-03653-x. Epub 2024 Jan 8. Pharm Res. 2024. PMID: 38191705
Impact of Manufacturing Process and Compounding on Properties and Quality of Follow-On GLP-1 Polypeptide Drugs.
Hach M, Engelund DK, Mysling S, Mogensen JE, Schelde O, Haselmann KF, Lamberth K, Vilhelmsen TK, Malmstrøm J, Højlys-Larsen KB, Rasmussen TS, Borch-Jensen J, Mortensen RW, Jensen TMT, Kesting JR, Catarig AM, Asgreen DJ, Christensen L, Staby A. Hach M, et al. Pharm Res. 2024 Oct;41(10):1991-2014. doi: 10.1007/s11095-024-03771-6. Epub 2024 Oct 8. Pharm Res. 2024. PMID: 39379664
Efficacy and Safety of Boswellia serrata and Apium graveolens L. Extract Against Knee Osteoarthritis and Cartilage Degeneration: A Randomized, Double-blind, Multicenter, Placebo-Controlled Clinical Trial.
Vaidya N, Agarwal R, Dipankar DG, Patkar H, Ganu G, Nagore D, Godse C, Mehta A, Mehta D, Nair S. Vaidya N, et al. Pharm Res. 2025 Feb;42(2):249-269. doi: 10.1007/s11095-025-03818-2. Epub 2025 Jan 28. Pharm Res. 2025. PMID: 39875757 Free PMC article. Clinical Trial.
Which Models are USEful?
Prybylski JP. Prybylski JP. Pharm Res. 2024 Dec;41(12):2271-2274. doi: 10.1007/s11095-024-03799-8. Epub 2024 Dec 2. Pharm Res. 2024. PMID: 39623143 No abstract available.
Coupling Drug Dissolution with BCS.
Simitopoulos A, Tsekouras A, Macheras P. Simitopoulos A, et al. Pharm Res. 2024 Mar;41(3):481-491. doi: 10.1007/s11095-024-03661-x. Epub 2024 Jan 30. Pharm Res. 2024. PMID: 38291164 Free PMC article.
Identification of Patients Who Require Two-Point Blood Sampling for the Peak and Trough Values Rather Than One-Point Blood Sampling for the Trough Value for the Evaluation of AUC of Vancomycin Using Bayesian Estimation.
Suzuki A, Samura M, Ishigo T, Fujii S, Ibe Y, Yoshida H, Tanaka H, Ebihara F, Maruyama T, Hamada Y, Fujihara H, Yamaguchi F, Nagumo F, Komatsu T, Tomizawa A, Takuma A, Chiba H, Nishi Y, Enoki Y, Taguchi K, Matsumoto K. Suzuki A, et al. Pharm Res. 2024 Nov;41(11):2161-2171. doi: 10.1007/s11095-024-03781-4. Epub 2024 Oct 21. Pharm Res. 2024. PMID: 39433691
10,257 results
You have reached the last available page of results. Please see the User Guide for more information.